hemophagocyt
syndrom
hp
fatal
complic
frequent
associ
viral
infect
childhood
hp
epsteinbarr
viru
ebv
major
caus
agent
red
blood
cell
rbc
predominantli
phagocytos
macrophag
investig
mechan
rbc
phagocytosi
trigger
ebv
infect
adopt
rabbit
model
ebvassoci
hp
previous
establish
use
herpesviru
papio
hvp
kinet
virushost
interact
studi
use
flow
cytometri
detect
emerg
antibodyco
rbc
well
antiplatelet
antibodi
peak
viru
load
period
week
hvp
inject
titer
increas
thereaft
presenc
antirbc
preced
rbc
phagocytosi
tissu
predict
fullblown
develop
hp
antirbc
antibodi
show
crossreact
paulbunnel
heterophil
antibodi
preabsorpt
hvpinfect
serum
control
rbc
remov
major
antirbc
activ
remark
reduc
rbc
phagocytosi
rbc
phagocytosi
specif
mediat
via
fc
fragment
antibodi
presenc
macrophag
activ
therefor
emerg
antirbc
antibodi
presenc
macrophag
activ
essenti
develop
hp
observ
anim
model
provid
potenti
mechan
hemophagocytosi
ebv
infect
hemophagocyt
syndrom
hp
fatal
disord
frequent
associ
microbi
infect
epsteinbarr
viru
ebv
cytomegaloviru
recent
influenza
viru
although
syndrom
divers
etiolog
genet
associ
hp
share
common
clinic
laboratori
featur
character
fever
hepatosplenomegali
hypercytokinemia
cytopenia
coagulopathi
system
prolifer
macrophag
phagocytosi
blood
cell
among
viral
pathogen
respons
hp
ebv
account
hp
case
young
children
pathogenesi
ebvassoci
hp
propos
result
dysregul
cytotox
tcell
respons
macrophag
activ
respons
ebv
infect
clinic
condit
xlink
lymphoprolif
disord
sporad
hemophagocyt
lymphohistiocytosi
hlh
phagocyt
process
macrophag
mean
random
event
involv
meticul
interact
ligand
surfac
phagocytos
cell
receptor
activ
macrophag
macrophag
activ
common
phenomenon
infecti
diseas
rel
rariti
hp
frequent
associ
hp
ebv
rais
possibl
ebv
may
play
specif
role
trigger
hp
furthermor
major
blood
cell
engulf
macrophag
ebvassoci
hp
red
blood
cell
rbc
platelet
distinct
predomin
lymphocyt
influenza
infect
condit
rosaidorfman
diseas
investig
specif
blood
cell
select
phagocytos
macrophag
differ
condit
help
clarifi
pathogenesi
virusassoci
hp
one
clue
resolv
issu
come
observ
viru
infect
may
induc
wide
spectrum
polyclon
bcell
antibodi
respons
rbc
platelet
lymphocyt
endotheli
cell
cell
type
opson
ie
prepar
phagocytosi
specif
antibodi
may
repres
select
target
phagocytosi
activ
macrophag
mediat
fc
receptor
note
product
paulbunnel
pb
heterophil
antibodi
agglutin
rbc
prevail
serolog
marker
acut
ebv
infect
infecti
mononucleosi
preval
antirbc
heterophil
antibodi
ebv
infect
may
explain
frequent
associ
hp
ebv
therefor
hypothes
antirbc
antibodi
may
play
pivot
role
trigger
phagocytosi
red
cell
ebvassoci
hp
test
hypothesi
adopt
rabbit
model
ebvassoci
hp
previous
establish
hayashi
colleagu
use
ebvrel
herpesviru
papio
hvp
rabbit
model
hvp
previous
found
infect
b
cell
distinct
predomin
exclus
infect
natur
killer
nk
cell
hlh
case
although
entir
similar
diseas
entiti
human
hlh
anim
model
still
repres
valuabl
tool
investig
pathogenesi
virusassoci
hp
studi
extend
studi
kinet
virushost
interact
develop
antiviru
antirbc
antibodi
longitudin
follow
correl
presenc
hemophagocytosi
tissu
vitro
ex
vivo
phagocytosi
assay
perform
clarifi
role
antirbc
antibodi
rbc
phagocytosi
activ
macrophag
mediat
via
fc
receptor
rabbit
model
ebvassoci
hp
previous
establish
hayashi
colleagu
use
ebv
homologu
viru
hvp
hvpproduc
baboon
lymphoblastoid
cell
line
cultur
rpmi
medium
life
technolog
inc
grand
island
ny
supplement
heatinactiv
fetal
bovin
serum
icn
aurora
oh
uml
penicillinstreptomycin
life
technolog
inc
cultur
supernat
cell
centrifug
g
minut
remov
cell
debri
filter
filter
millipor
billerica
centrifug
g
beckman
coulter
hialeah
fl
minut
obtain
concentr
viru
stock
new
zealand
white
rabbit
weigh
kg
obtain
taiwan
livestock
research
institut
tainan
taiwan
rabbit
inocul
intraven
viru
stock
concentr
ml
cultur
supernat
cell
contain
copi
hvp
quantifi
realtim
polymeras
chain
reaction
pcr
control
rabbit
inocul
phosphatebuff
salin
pb
inocul
viru
pellet
rabbit
sacrif
weekli
euthanasia
excess
pentobarbit
sodium
mtc
pharmaceut
hamilton
canada
control
rabbit
sacrif
hvpinfect
rabbit
die
ill
organ
includ
spleen
lymph
node
liver
kidney
thymu
lung
spinal
cord
examin
macroscop
fix
formalin
formalinfix
paraffinembed
tissu
block
section
thick
stain
convent
histopatholog
hematoxylin
eosin
bone
marrow
blood
smear
rabbit
stain
modifi
wright
liu
aliu
b
stain
immunohistochem
studi
distribut
cell
b
cell
tissu
freshli
frozen
specimen
section
thick
immunostain
monoclon
mous
antihuman
bcell
marker
crossreact
rabbit
dako
glostrup
denmark
cell
serotec
ltd
oxford
uk
minut
room
temperatur
clone
monoclon
antibodi
use
studi
specif
cell
crossreact
b
cell
cell
wash
twice
pb
immunoreact
goat
antimous
horseradish
peroxidaseconjug
igg
horseradish
peroxidas
amersham
bioscienc
london
uk
minut
room
temperatur
wash
section
react
aec
substrat
dako
examin
microscop
antivca
igg
sera
determin
indirect
immunofluoresc
assay
use
ebvindirect
immunofluoresc
assay
slide
meridian
bioscienc
cincinnati
oh
differ
dilut
rabbit
sera
ad
well
ebvindirect
immunofluoresc
assay
slide
incub
minut
room
temperatur
slide
wash
pb
react
fluorescein
isothiocyan
fitc
label
goat
antirabbit
igg
jackson
immunoresearch
west
grove
pa
incub
room
temperatur
minut
slide
wash
observ
fluoresc
microscop
control
secondari
antibodi
alon
fitclabel
antirabbit
igg
anoth
irrelev
secondari
antibodi
fitclabel
goat
antimous
igg
jackson
immunoresearch
simultan
run
test
mononuclear
cell
rabbit
isol
whole
blood
spleen
ficol
gradient
separ
label
incub
mous
antirabbit
igm
b
cell
antirabbit
cell
antihuman
crossreact
rabbit
serotec
ltd
minut
room
temperatur
cell
wash
twice
pb
magnet
label
goat
antimous
igg
microbead
miltenyi
biotec
auburn
ca
minut
wash
cell
igm
b
cell
monocytesmacrophag
separ
immunomagnet
procedur
incorpor
mac
system
miltenyi
biotec
detect
hvp
viru
load
sera
infect
rabbit
quantit
realtim
pcr
perform
use
lightcycl
roch
diagnost
gmbh
mannheim
germani
lightcyclerfaststart
dna
master
sybr
green
roch
diagnost
gmbh
viru
dna
rabbit
sera
extract
qiaamp
dna
mini
kit
qiagen
gmbh
accord
manufactur
protocol
total
l
sampl
dna
use
reaction
volum
l
assay
contain
mmoll
magnesium
chlorid
moll
primer
l
lightcycl
faststart
dna
master
sybr
green
mixtur
reaction
condit
assay
follow
one
segment
denatur
minut
cycl
amplif
three
segment
second
second
second
three
segment
melt
minut
final
one
segment
cool
second
primer
use
assay
rabbit
spleen
lymph
node
thymus
lung
liver
fix
formalin
paraffinembed
section
thick
put
onto
glass
slide
subject
detect
situ
hybrid
perform
accord
manufactur
protocol
provid
ebv
probe
situ
hybrid
kit
novocastra
laboratori
ltd
newcastl
tyne
uk
rabbit
blood
sampl
collect
inocul
hvp
rabbit
red
cell
isol
whole
blood
ficol
gradient
separ
wash
twice
pb
incub
fitclabel
antirabbit
immunoglobulin
dako
minut
set
forward
scattersid
scatter
detector
log
mode
gate
rbc
region
surfac
fluoresc
rabbit
red
cell
measur
facscalibur
becton
dickinson
compani
franklin
lake
nj
analyz
cellquest
softwar
fitclabel
mous
igg
becton
dickinson
compani
use
isotyp
control
experi
clarifi
whether
antiplatelet
antibodi
also
present
anim
model
assay
antiplatelet
antibodi
also
perform
plateletrich
plasma
separ
whole
blood
centrifug
g
minut
wash
count
platelet
incub
hvpinfect
rabbit
serum
minut
platelet
wash
twice
pb
doublelabel
antirabbit
pe
serotec
ltd
antirabbit
ig
fitc
dako
anoth
minut
wash
pb
fluoresc
platelet
measur
analyz
facscalibur
cellular
enzymelink
immunosorb
assay
platelet
seed
well
plate
incub
hour
fixat
paraformaldehyd
ad
well
care
wash
well
incub
room
temperatur
minut
block
bovin
serum
albumin
differ
dilut
rabbit
plasma
ad
well
incub
room
temperatur
hour
horseradish
peroxidaseconjug
antirabbit
immunoglobulin
amersham
bioscienc
ad
wash
plate
incub
hour
final
tetramethyl
benzidin
substrat
appli
elicit
chromogen
signal
plate
measur
enzymelink
immunosorb
assay
reader
determin
pb
heterophil
antibodi
rabbit
sera
perform
monospot
latex
kit
meridian
bioscienc
contain
pb
heterophil
determin
briefli
l
sampl
ad
one
well
dispos
slide
drop
latex
reagent
ad
next
drop
sampl
mix
rotat
gentli
minut
mixtur
examin
presenc
absenc
agglutin
investig
whether
heterophil
antibodi
repres
predomin
compon
antir
cell
antibodi
infect
serum
preabsorpt
test
perform
infect
rabbit
sera
preincub
normal
rabbit
red
cell
minut
twice
perform
agglutin
assay
promonocyt
cell
line
differenti
activ
ngml
phorbol
ester
tpa
sigma
st
loui
mo
hour
fitclabel
latex
bead
sigma
ad
tpatreat
untreat
cell
incub
hour
wash
four
time
pb
phagocytosi
could
observ
fluoresc
microscopi
investig
phagocytosi
red
cell
macrophag
normal
human
red
cell
coombstreat
cell
gamma
biolog
inc
houston
tx
label
fitc
use
flurorotag
fitc
conjug
kit
sigma
fitclabel
normal
human
red
cell
fitclabel
coombstreat
cell
use
studi
fitclabel
target
cell
incub
tpaactiv
cell
hour
incub
unengulf
red
cell
lyse
rbc
lysi
buffer
remain
cell
examin
fluoresc
microscopi
flow
cytometri
rabbit
monocyt
isol
pbmc
use
immunomagnet
approach
mention
rabbit
monocyt
activ
tpa
test
engulf
fitclabel
normal
rabbit
red
cell
precoat
coat
hvpinfect
rabbit
sera
coincub
activ
monocyt
red
cell
hour
phagocytosi
red
cell
examin
fluoresc
microscopi
determin
whether
phagocytosi
red
cell
mediat
via
fc
fragment
fab
fc
fragment
separ
prepar
papain
digest
use
immunopur
fab
prepar
kit
pierc
rockford
il
brief
mg
purifi
human
igg
sigma
digest
immobil
papain
hour
chromatographi
use
purifi
fab
fc
fragment
igg
column
protein
g
pierc
fc
fab
fragment
whole
igg
ad
blocker
final
concentr
mgml
phagocytosi
assay
describ
total
rabbit
use
studi
eight
receiv
hvp
inocul
three
control
five
hvpinfect
rabbit
serial
sacrif
euthanasia
observ
dynam
virushost
interact
sequenti
develop
diseas
remain
three
hvpinfect
rabbit
develop
fulmin
hp
die
within
month
day
viru
inocul
appear
physic
healthi
last
week
die
rabbit
first
lost
appetit
becam
emaci
rhinorrhea
admix
blood
develop
dyspnea
three
control
rabbit
free
symptom
remain
healthi
end
experi
necropsi
infect
rabbit
reveal
dark
purpl
congest
swollen
lymph
node
well
hepatosplenomegali
kidney
thymus
look
normal
lung
show
congest
edema
control
rabbit
look
otherwis
normal
histopatholog
examin
infect
rabbit
tissu
show
progress
lymphoid
deplet
spleen
lymph
node
figur
lymphoid
infiltr
predominantli
cell
around
perivascular
area
mani
organ
liver
kidney
lung
liver
show
mild
fatti
chang
portal
infiltr
predomin
tlymphoid
cell
bone
marrow
show
mild
hyperplasia
day
progress
mark
hypoplasia
death
histolog
pictur
hemophagocytosi
first
appear
week
hvp
inocul
predomin
engulf
red
cell
macrophag
sinus
spleen
lymph
node
bone
marrow
hvpinfect
rabbit
figur
sever
red
cell
engulf
activ
macrophag
associ
diseas
progress
plasma
cell
atyp
lymphocyt
nucleat
red
cell
could
also
observ
blood
smear
hvpinfect
rabbit
hp
data
shown
sera
obtain
hvpinocul
rabbit
antivca
iggposit
wherea
sera
preinocul
rabbit
control
rabbit
show
neg
reactiv
although
seroconvers
vari
titer
among
hvpinfect
rabbit
antibodi
vca
becam
detect
day
persist
thereaft
figur
presenc
viral
genom
pbmc
infect
rabbit
assess
pcr
detect
gene
region
hvp
dna
shown
figur
top
genom
data
shown
detect
pbmc
day
viru
inocul
quantit
pcr
studi
show
hvp
dna
rabbit
sera
detect
day
viral
load
peak
week
hvp
inocul
declin
thereaft
hvp
dna
could
also
detect
pcr
tissu
spleen
lymph
node
liver
lung
hvpinfect
rabbit
data
shown
immunomagnet
purif
hvp
dna
could
detect
fraction
purifi
cell
igm
b
cell
monocyt
pbmc
hvpinfect
rabbit
day
viru
inocul
figur
bottom
situ
hybrid
perform
formalinfix
tissu
hvpinfect
rabbit
rna
hvp
detect
lymphocyt
spleen
figur
top
lymph
node
thymus
signal
first
detect
margin
zone
white
pulp
spleen
day
extens
spleen
figur
bottom
lymph
node
follow
week
could
also
detect
infiltr
lymphocyt
lung
liver
obtain
week
hvp
inocul
necropsi
immunohistochem
studi
reveal
infiltr
lymphoid
cell
liver
lung
mostli
cell
rare
b
cell
data
shown
situ
signal
correl
white
pulp
spleen
contain
band
timmunoreact
cell
figur
top
confirm
specif
hvpinfect
cell
immunomagnet
purif
fraction
b
cell
perform
spleen
lymphocyt
hvp
dna
could
detect
fraction
b
cell
spleen
figur
bottom
right
quantit
realtim
pcr
analysi
reveal
b
cell
contain
mean
copi
hvp
genom
per
ng
cell
dna
higher
copi
hvp
genom
tcell
fraction
fraction
contain
cell
avail
dna
extract
analysi
use
fitclabel
antirabbit
immunoglobulin
flow
cytometr
analysi
found
red
cell
hvpinfect
rabbit
coat
antibodi
antibodyco
red
cell
appear
around
week
viru
inocul
reactiv
increas
rapidli
thereaft
day
day
day
last
week
immedi
death
red
cell
coat
antibodi
figur
consid
patient
infecti
mononucleosi
produc
heterophil
antibodi
agglutin
red
cell
specul
link
may
exist
heterophil
antibodi
antir
cell
autoantibodi
rabbit
model
agglutin
test
use
monospot
kit
show
hvpinfect
rabbit
produc
pb
heterophil
antibodi
wherea
control
rabbit
figur
top
antibodyco
red
cell
close
correl
titer
heterophil
antibodi
diseas
progress
tabl
preabsorpt
hvpinfect
sera
normal
rabbit
erythrocyt
could
significantli
reduc
agglutin
activ
heterophil
antibodi
titer
heterophil
antibodi
decreas
preabsorpt
figur
bottom
result
indic
antir
cell
antibodi
serum
hvpinfect
rabbit
crossreact
pb
heterophil
antibodi
rabbit
model
rabbit
model
observ
platelet
hvpinfect
rabbit
decreas
diseas
progress
data
shown
clarifi
whether
hvpinfect
rabbit
also
develop
antiplatelet
antibodi
gate
platelet
marker
figur
cell
observ
antibodyco
platelet
shown
figur
antibodyco
platelet
could
observ
day
hvp
inocul
similar
antirbc
antibodi
titer
antiplatelet
antibodi
increas
correl
sever
diseas
figur
b
summar
kinet
virushost
interact
hp
anim
model
first
event
detect
viru
inocul
appear
hvp
dna
rabbit
sera
day
follow
product
antivca
antibodi
sera
presenc
viral
genom
pbmc
tissu
day
product
antirbcheterophil
antibodi
develop
rel
late
stage
usual
occur
viru
load
peak
week
hvp
inocul
increas
rapidli
thereaft
notabl
red
cell
phagocytosi
rabbit
tissu
could
observ
emerg
antirbc
antibodi
suggest
coat
red
cell
antibodi
prerequisit
phagocytosi
red
cell
increas
titer
antirbc
antibodi
repres
reliabl
indic
predict
fullblown
diseas
impend
mortal
hvpinfect
rabbit
clarifi
whether
presenc
antibodi
red
cell
macrophag
activ
essenti
hemophagocyt
process
perform
serial
vitro
phagocyt
studi
first
human
promonocyt
cell
line
treat
without
tpa
test
activ
engulf
fitclabel
latex
bead
cell
could
phagocytos
fluoresc
bead
cell
preactiv
tpa
data
shown
furthermor
tpatreat
cell
could
engulf
coombstreat
cell
figur
right
coomb
cell
control
red
cell
figur
control
indic
coat
red
cell
antirbc
antibodi
requir
phagocytosi
activ
macrophag
clarif
relationship
titer
antibodi
present
red
cell
surfac
degre
rbc
phagocytosi
differ
ratio
antibodyco
rbc
use
measur
percentag
phagocytosi
flow
cytometri
fraction
macrophag
gate
figur
top
left
fluoresc
intens
gate
macrophag
measur
coomb
cell
studi
show
higher
nonspecif
background
attribut
adher
rbc
lysat
surfac
activ
macrophag
fluoresc
intens
phagocytos
coomb
cell
measur
region
figur
bottom
left
shown
figur
right
activ
rbc
phagocytosi
macrophag
increas
ratio
coomb
cell
human
iggcoat
rbc
ex
vivo
phagocytosi
assay
show
tpaactiv
rabbit
monocyt
could
engulf
rabbit
erythrocyt
pretreat
hvpinfect
rabbit
sera
figur
right
uninfect
sera
figur
left
defin
clearli
specif
immunoglobulin
fragment
react
macrophag
excess
fab
fragment
fc
fragment
whole
igg
molecul
use
compet
antibodi
coomb
cell
figur
demonstr
fc
fragment
well
whole
igg
molecul
fab
fragment
could
complet
block
engulf
coombstreat
cell
tpaactiv
cell
indic
phagocytosi
mediat
fc
receptor
taken
togeth
data
shown
indic
presenc
antir
cell
antibodi
macrophag
activ
essenti
rbc
phagocytosi
mediat
via
fc
fragment
decad
physician
investig
puzzl
mechan
hemophagocytosi
human
diseas
studi
demonstr
vivo
ex
vivo
vitro
studi
emerg
antirbc
probabl
antiplatelet
antibodi
hvp
infect
pivot
trigger
phagocyt
process
rabbit
model
ebvassoci
hp
base
dynam
kinet
virushost
interact
vivo
shown
figur
emerg
antirbc
antibodi
alway
preced
develop
rbc
phagocytosi
tissu
increas
titer
antirbc
antibodi
predict
fullblown
develop
hp
impend
mortal
hvpinfect
rabbit
given
rabbit
model
ebvassoci
hp
entir
similar
human
hlh
case
find
observ
studi
still
provid
valuabl
inform
mechan
hemophagocytosi
virusassoci
hp
although
presenc
antirbc
antibodi
pb
heterophil
antibodi
anim
model
explain
frequent
associ
childhood
hp
ebv
ubiquit
ebv
infect
rel
rariti
ebvassoci
hp
howev
challeng
role
antirbc
antibodi
develop
ebvhp
shown
studi
demonstr
phagocyt
process
specif
type
blood
cell
phagocytos
macrophag
repres
nonrandom
biolog
event
absenc
antirbc
antibodi
red
cell
phagocytosi
occur
even
presenc
ac
tivat
macrophag
vice
versa
observ
may
therefor
explain
rel
infrequ
hp
viral
infect
observ
ebv
virusassoci
hlh
patient
ebvassoci
hp
usual
develop
patient
abnorm
immun
disord
xlink
lymphoprolif
disord
rare
condit
ebv
infect
nk
cell
hlh
nkt
cell
lymphoma
xlink
lymphoprolif
disord
mutat
suppressor
sap
protein
lead
dysregul
ctl
respons
primari
ebv
infect
sporad
hlh
patient
ebv
usual
infect
nk
cell
rather
b
cell
ebv
latent
membran
demonstr
initi
trafsnfbsap
erk
signal
pathway
activ
cell
upregul
cytokin
secret
altern
hlh
may
result
mutat
perforin
gene
lead
ineffect
ctl
respons
ebv
infect
distinct
predomin
exclus
infect
nk
cell
ebv
hlh
hvp
infect
cell
b
cell
possibl
macrophag
rabbit
model
viru
infect
b
cell
may
induc
polyclon
activ
b
lymphocyt
lead
format
wide
varieti
autoantibodi
includ
direct
smooth
muscl
blood
group
lymphocyt
platelet
erythrocyt
summar
data
present
studi
propos
develop
hp
requir
two
essenti
event
one
involv
dysregul
ctl
immun
respons
result
hypersecret
cytokin
subsequ
activ
macrophag
branch
involv
autoreact
polyclon
bcell
respons
produc
autoantibodi
blood
cell
whether
monocytesmacrophag
infect
ebv
still
controversi
recent
studi
howev
demonstr
capabl
ebv
infect
replic
freshli
isol
human
monocyt
infect
macrophag
ebv
may
activ
macrophag
anim
model
infect
tissu
macrophag
hvp
inconclus
cell
obtain
flow
cytometr
analysi
howev
hvp
dna
could
detect
monocyt
fraction
pbmc
therefor
possibl
hvp
infect
macrophag
may
exist
infect
monocytesmacrophag
ebv
hvp
may
activ
macrophag
secret
monokin
make
cytokin
storm
wors
hp
among
wide
varieti
autoantibodi
produc
pb
heterophil
antibodi
specif
associ
primari
ebv
infect
past
decad
extens
effort
given
studi
crossspeci
reactiv
pattern
antigen
epitop
pb
heterophil
antibodi
epitop
pb
antibodi
erythrocyt
membran
recogn
sialoglycopeptid
contain
olink
disialyl
galgalnac
oligopeptid
epitop
form
basi
commerci
avail
kit
current
use
antibodi
detect
diagnosi
infecti
mononucleosi
adopt
studi
sever
explan
propos
describ
mechan
develop
heterophil
antibodi
ebv
infect
molecular
mimicri
host
cell
dna
protein
viral
gene
product
prevail
theori
preabsorpt
hvpinfect
sera
rabbit
red
cell
studi
titer
heterophil
antibodi
reduc
significantli
suggest
pb
heterophil
antibodi
may
crossreact
even
repres
major
compon
antirbc
antibodi
hvpinfect
rabbit
serum
one
critic
question
whether
find
antirbc
antibodi
anim
model
appli
human
hp
hlh
patient
retrospect
retriev
serum
sampl
total
ebvassoci
hp
patient
indirect
coomb
test
eight
posit
wch
ij
unpublish
data
suggest
antirbc
antibodi
exist
ebvhp
patient
perform
prospect
multicent
studi
use
direct
coomb
test
clarifi
posit
antirbc
antibodi
ebvhp
patient
studi
clarifi
kinet
virushost
interact
anim
model
ebvassoci
hp
hvp
virus
appear
first
infect
lymphoid
cell
margin
zone
spleen
follow
extens
infect
spleen
lymph
node
liver
lung
mortal
rabbit
develop
symptom
sign
typic
human
hp
coagulopathi
cytopenia
deplet
lymphoid
system
bone
marrow
limit
commerci
avail
antibodi
rabbit
especi
cytokin
antigen
blood
cell
detail
descript
cytokin
chang
avail
studi
although
hvp
rabbit
model
hp
entir
similar
human
hlh
case
find
observ
studi
still
provid
valuabl
inform
understand
pathogenesi
human
ebvhp
importantli
anim
model
also
provid
valuabl
tool
design
therapeut
trial
improv
manag
virusassoci
hp
patient
